淋巴细胞-话题@MedSci

#淋巴细胞#

495篇内容 | 7060人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1302026, encodeId=dbb81302026d1, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=AACE 2016：神经内分泌肿瘤与B淋巴细胞刺激因子水平研究, objectType=article, longId=69444, objectId=f3a56944487, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f3a56944487, replyNumber=0, likeNumber=99, createdTime=2016-05-31, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f3a56944487, moduleTitle=AACE 2016：神经内分泌肿瘤与B淋巴细胞刺激因子水平研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f3a56944487)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302024, encodeId=747e130202493, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=内免疫疗法的信心！我国生物技术公司ICT CAR-T治疗B淋巴细胞白血病治愈率达90%, objectType=article, longId=67957, objectId=792e6e95716, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=792e6e95716, replyNumber=0, likeNumber=50, createdTime=2016-05-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=792e6e95716, moduleTitle=内免疫疗法的信心！我国生物技术公司ICT CAR-T治疗B淋巴细胞白血病治愈率达90%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=792e6e95716)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302025, encodeId=0f11130202533, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=6个适应症！FDA批准艾伯维突破性药物Imbruvica治疗小淋巴细胞性淋巴瘤（SLL）, objectType=article, longId=67960, objectId=cc206e96084, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc206e96084, replyNumber=0, likeNumber=70, createdTime=2016-05-12, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc206e96084, moduleTitle=6个适应症！FDA批准艾伯维突破性药物Imbruvica治疗小淋巴细胞性淋巴瘤（SLL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc206e96084)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302023, encodeId=4149130202362, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=FDA授予安进BiTE免疫疗法Blincyto治疗儿科急性淋巴细胞白血病（ALL）的优先审查资格, objectType=article, longId=67544, objectId=c7dd6e544b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c7dd6e544b6, replyNumber=0, likeNumber=0, createdTime=2016-05-06, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c7dd6e544b6, moduleTitle=FDA授予安进BiTE免疫疗法Blincyto治疗儿科急性淋巴细胞白血病（ALL）的优先审查资格, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c7dd6e544b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302022, encodeId=2b1113020221c, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！, objectType=article, longId=67349, objectId=89f06e34900, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=89f06e34900, replyNumber=0, likeNumber=91, createdTime=2016-05-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=89f06e34900, moduleTitle=JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=89f06e34900)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302021, encodeId=c5c5130202126, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=eLife：脂质可调节淋巴细胞能动性, objectType=article, longId=66415, objectId=28e7664158c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=28e7664158c, replyNumber=0, likeNumber=68, createdTime=2016-04-14, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=28e7664158c, moduleTitle=eLife：脂质可调节淋巴细胞能动性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=28e7664158c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302020, encodeId=2e32130202032, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, objectType=article, longId=64673, objectId=6448646e38c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6448646e38c, replyNumber=0, likeNumber=63, createdTime=2016-03-13, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6448646e38c, moduleTitle=5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6448646e38c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302019, encodeId=e8171302019d3, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet Haematol：选择剖宫产，后代患急性淋巴细胞白血病(ALL)的风险增加, objectType=article, longId=63906, objectId=33686390658, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33686390658, replyNumber=0, likeNumber=71, createdTime=2016-03-01, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33686390658, moduleTitle=Lancet Haematol：选择剖宫产，后代患急性淋巴细胞白血病(ALL)的风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33686390658)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302018, encodeId=b8f313020181c, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JCO：肿瘤淋巴细胞浸润可以作为预后标志物, objectType=article, longId=63098, objectId=b602630980d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b602630980d, replyNumber=0, likeNumber=86, createdTime=2016-02-10, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b602630980d, moduleTitle=JCO：肿瘤淋巴细胞浸润可以作为预后标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b602630980d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302017, encodeId=6fe2130201e0f, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet Haematol：阿伦单抗治疗T细胞大颗粒淋巴细胞白血病的安全性和有效性, objectType=article, longId=62503, objectId=ae97625036d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae97625036d, replyNumber=0, likeNumber=29, createdTime=2016-01-24, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae97625036d, moduleTitle=Lancet Haematol：阿伦单抗治疗T细胞大颗粒淋巴细胞白血病的安全性和有效性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae97625036d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302016, encodeId=1fa91302016c2, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=NEJM：抗淋巴细胞球蛋白可减少慢性移植物抗宿主病的发生, objectType=article, longId=61795, objectId=ee8161e95cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee8161e95cc, replyNumber=0, likeNumber=56, createdTime=2016-01-08, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee8161e95cc, moduleTitle=NEJM：抗淋巴细胞球蛋白可减少慢性移植物抗宿主病的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee8161e95cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302015, encodeId=070c1302015f0, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=NEJM：Acalabrutinib有望治疗慢性淋巴细胞白血病（CLL）患者, objectType=article, longId=61694, objectId=eb9d6169425, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=eb9d6169425, replyNumber=0, likeNumber=65, createdTime=2016-01-07, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=eb9d6169425, moduleTitle=NEJM：Acalabrutinib有望治疗慢性淋巴细胞白血病（CLL）患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=eb9d6169425)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302014, encodeId=04581302014b0, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet Haematology：阿仑单抗治疗T细胞大颗粒淋巴细胞性白血病患者可减少毒性, objectType=article, longId=60750, objectId=8f1260e505d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f1260e505d, replyNumber=0, likeNumber=91, createdTime=2015-12-19, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f1260e505d, moduleTitle=Lancet Haematology：阿仑单抗治疗T细胞大颗粒淋巴细胞性白血病患者可减少毒性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f1260e505d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302013, encodeId=e04d130201360, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nat Immunol：阑尾中先天淋巴细胞(ILC)可能有巨大作用, objectType=article, longId=60435, objectId=c73760435be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c73760435be, replyNumber=0, likeNumber=70, createdTime=2015-12-10, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c73760435be, moduleTitle=Nat Immunol：阑尾中先天淋巴细胞(ILC)可能有巨大作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c73760435be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302012, encodeId=fe2a130201271, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=NEJM：venetoclax治疗复发慢性淋巴细胞性白血病初见成效, objectType=article, longId=60349, objectId=43666034930, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=43666034930, replyNumber=0, likeNumber=66, createdTime=2015-12-08, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=43666034930, moduleTitle=NEJM：venetoclax治疗复发慢性淋巴细胞性白血病初见成效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=43666034930)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302011, encodeId=8e4a13020111e, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=英国医生采用基因编辑CART细胞成功治愈1岁急性淋巴细胞白血病婴儿, objectType=article, longId=58488, objectId=a89f58488c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a89f58488c2, replyNumber=0, likeNumber=71, createdTime=2015-11-09, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a89f58488c2, moduleTitle=英国医生采用基因编辑CART细胞成功治愈1岁急性淋巴细胞白血病婴儿, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a89f58488c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302010, encodeId=08b0130201092, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Sci Transl Med：CAR-T对难治或复发性慢性淋巴细胞白血病疗效显著, objectType=article, longId=56369, objectId=958e5636923, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=958e5636923, replyNumber=0, likeNumber=69, createdTime=2015-09-22, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=958e5636923, moduleTitle=Sci Transl Med：CAR-T对难治或复发性慢性淋巴细胞白血病疗效显著, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=958e5636923)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302009, encodeId=e2431302009d0, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Lancet Oncol：Ofatumumab维持治疗慢性淋巴细胞白血病效果, objectType=article, longId=56169, objectId=2193561692f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2193561692f, replyNumber=0, likeNumber=61, createdTime=2015-09-16, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2193561692f, moduleTitle=Lancet Oncol：Ofatumumab维持治疗慢性淋巴细胞白血病效果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2193561692f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302008, encodeId=765f13020080d, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=Nat Commun：细胞代谢紊乱导致了弥散性大B淋巴细胞瘤的发生, objectType=article, longId=53731, objectId=d24153e31f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d24153e31f3, replyNumber=0, likeNumber=59, createdTime=2015-07-25, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d24153e31f3, moduleTitle=Nat Commun：细胞代谢紊乱导致了弥散性大B淋巴细胞瘤的发生, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d24153e31f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1302007, encodeId=17a4130200e50, content=<a href='/topic/show?id=82a6659902c' target=_blank style='color:#2F92EE;'>#淋巴细胞#</a>, objectTitle=JAMA Oncol：肿瘤浸润淋巴细胞（TILs）可能是HER2阳性早期乳腺癌预后指标(NeoALTTO试验), objectType=article, longId=53522, objectId=0ee253522f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0ee253522f6, replyNumber=0, likeNumber=68, createdTime=2015-07-21, rootId=0, userName=wetgdt, userId=1e34303, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0ee253522f6, moduleTitle=JAMA Oncol：肿瘤浸润淋巴细胞（TILs）可能是HER2阳性早期乳腺癌预后指标(NeoALTTO试验), moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0ee253522f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

淋巴细胞

2020-05-29

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

AACE 2016：神经内分泌肿瘤与B淋巴细胞刺激因子水平研究

2016-05-31

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

内免疫疗法的信心！我国生物技术公司ICT CAR-T治疗B淋巴细胞白血病治愈率达90%

2016-05-12

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

6个适应症！FDA批准艾伯维突破性药物Imbruvica治疗小淋巴细胞性淋巴瘤（SLL）

2016-05-12

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

FDA授予安进BiTE免疫疗法Blincyto治疗儿科急性淋巴细胞白血病（ALL）的优先审查资格

2016-05-06

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JCI：CAR-T细胞治疗对复发或难治性急性B淋巴细胞白血病有神奇效果！

2016-05-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

eLife：脂质可调节淋巴细胞能动性

2016-04-14

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

5个适应证！FDA批准艾伯维突破性抗癌药Imbruvica一线治疗慢性淋巴细胞白血病（CLL）

2016-03-13

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet Haematol：选择剖宫产，后代患急性淋巴细胞白血病(ALL)的风险增加

2016-03-01

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JCO：肿瘤淋巴细胞浸润可以作为预后标志物

2016-02-10

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet Haematol：阿伦单抗治疗T细胞大颗粒淋巴细胞白血病的安全性和有效性

2016-01-24

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

NEJM：抗淋巴细胞球蛋白可减少慢性移植物抗宿主病的发生

2016-01-08

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

NEJM：Acalabrutinib有望治疗慢性淋巴细胞白血病（CLL）患者

2016-01-07

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet Haematology：阿仑单抗治疗T细胞大颗粒淋巴细胞性白血病患者可减少毒性

2015-12-19

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Nat Immunol：阑尾中先天淋巴细胞(ILC)可能有巨大作用

2015-12-10

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

NEJM：venetoclax治疗复发慢性淋巴细胞性白血病初见成效

2015-12-08

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

英国医生采用基因编辑CART细胞成功治愈1岁急性淋巴细胞白血病婴儿

2015-11-09

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Sci Transl Med：CAR-T对难治或复发性慢性淋巴细胞白血病疗效显著

2015-09-22

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Lancet Oncol：Ofatumumab维持治疗慢性淋巴细胞白血病效果

2015-09-16

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

Nat Commun：细胞代谢紊乱导致了弥散性大B淋巴细胞瘤的发生

2015-07-25

wetgdt (审核中...)

前往app查看评论内容

#淋巴细胞#

JAMA Oncol：肿瘤浸润淋巴细胞（TILs）可能是HER2阳性早期乳腺癌预后指标(NeoALTTO试验)

2015-07-21

科室
- - 订阅+
  - 更多科室
工具
服务